key: cord-1024350-5chz50xh
authors: Kim, Ha Nui; Yoon, Soo-Young; Lim, Chae Seung; Lee, Chang Kyu; Yoon, Jung
title: Phylogenetic analysis of human parainfluenza type 3 virus strains responsible for the outbreak during the COVID-19 pandemic in Seoul, South Korea
date: 2022-03-16
journal: bioRxiv
DOI: 10.1101/2022.03.15.484550
sha: e5a4ca94a256734dfe860170bb33b094ae59590e
doc_id: 1024350
cord_uid: 5chz50xh

Background Human parainfluenza virus 3 (HPIV3) is a major respiratory pathogen that causes acute respiratory infections in infants and children. Since September 2021, an out-of-season HPIV3 rebound has been noted in Korea. The objective of this study was to analyze the molecular characteristics of the HPIV3 strains responsible for the outbreak in Seoul, South Korea. Methods A total of 61 HPIV3-positive nasopharyngeal swab specimens were collected between October and November 2021. Using 33 HPIV3-positive specimens, partial nucleotide sequences of the HPIV3 hemagglutinin-neuraminidase (HN) gene were aligned with previously published HN gene sequences for phylogenetic and genetic distance (p-distance) analyses. Results Phylogenetic tree revealed that all Seoul HPIV3 strains grouped within the phylogenetic subcluster C3. However, these strains formed a unique cluster that branched separately from the C3a lineage. This cluster showed 99% bootstrap support with a p-distance < 0.001. Genetic distances within the other C3 lineages ranged from 0.013 (C3a) to 0.023 (C3c). Deduced amino acid sequences of the HN gene revealed four protein substitutions in Seoul HPIV3 strains that have rarely been observed in other reference strains: A22T, K31N, G387S, and E514K. Conclusions Phylogenetic analysis of Seoul HPIV3 strains revealed that the strain belonged to a separate cluster within subcluster C3. Genetic distances among strains within subcluster C3 suggest the emergence of a new genetic lineage. The emergence of a new genetic lineage could pose a potential risk of a new epidemic. Further monitoring of the circulating HPIV3 strains is needed to understand the importance of newly discovered mutations.

infections, and a substantial decrease in the incidence of respiratory viral infections other than 74 COVID-19 has been reported (6, 7). Interestingly, in late 2020, a delayed outbreak of RSV 75 was reported in some countries (8). In Korea, an out-of-season HPIV3 outbreak has been 76 reported during the COVID-19 pandemic in September 2021. From the 39 th to 42 nd week of 77 2021, an unprecedented high positivity rate of 41.6% was noted (9). Moreover, the HPIV3 78 epidemic differed in that the HPIV3 detection was the most prevalent among infants and 79 children, and other types of HPIV were not detected (9, 10).

HPIV3 is an enveloped, negative-sense, single-stranded RNA virus, with 15,462 nucleotides 81 that encode six genes and eight proteins (3). The major antigens responsible for infecting the 82 host cells are its two surface glycoproteins; the hemagglutinin-neuraminidase (HN) and 83 5 fusion (F) proteins. The HN protein regulates virus-host interactions and has both 84 hemagglutinin and neuraminidase activity (11). In addition, the HN protein affects the F 85 protein's function in mediating membrane fusion with host cells (12). Because of its 86 antigenicity and variability, the HN gene has been the preferred target gene region for the 87 phylogenetic analysis of HPIV3 (13). HPIV3s are classified into three clusters (clusters A-C) 88 according to the characteristics of the HN gene (11) under the best-fit TN93 + G substitution model, as predicted by MEGA X. The reliability of 131 the branching order was assessed using 1,000 bootstrap replicates, and clades with values > 132 70% were considered significant.

In addition, a time-scaled phylogenetic tree was reconstructed using the Bayesian Markov belonged to male, and 29 (47.5%) belonged to female patients. The median age of the 174 patients was 24 months, and most (70.5%) were infants and children aged below 7 years 175 (Table 1) . A diagnosis of upper respiratory tract infection (URTI) was common (67.2%). The 176 manifestation as LRTI including pneumonia and bronchiolitis was observed in 34.4% and 6.6% 177 of patients, respectively. The most frequent diagnosis in infants and children was URTI 178 (83.7%, n = 36/43), followed by croup (25.6%, n = 11/43), bronchiolitis (9.3%, n = 4/43), and 179 pneumonia (9.3%, n = 4/43). 

As COVID-19 measures were relaxed, unexpected outbreaks due to infections by the 228 suppressed respiratory viruses, so-called "out of season" epidemics, have been observed (30). reduced natural exposure to these viruses can be lead to lowered population immunity (7).

In our study, compared to that before the COVID-19 pandemic, an almost 2-fold (ranging 238 from 1.88-to 2.95-fold) increase in the peak positivity rate was detected. Unlike other HPIVs, 239 HPIV3 mainly infects young infants and causes severe LRTI, such as bronchiolitis and 240 12 pneumonia (1). Despite the high detection rate of HPIV3, especially in infants and children, 241 compared to that reported in a previous study conducted in our institute (31), a lower 242 frequency of pneumonia and bronchiolitis was observed. The most common manifestation of 243 LRTI was croup.

According to recent studies from Argentina, Spain, and China, strains belonging to cluster C 245 are predominantly prevalent (28, 32, 33) . Phylogenetic analysis using the HN gene showed 246 that all Seoul HPIV3 strains were classified as subcluster C3; however, they formed a distinct The data that support the findings of this study are available from the corresponding author 316 upon reasonable request. 

Parainfluenza viruses

Epidemiology and clinical presentation of the four human 332 parainfluenza virus types

Fields' Virology Sixth Edition Lippincott Williams & 334

Epidemiology of parainfluenza virus types 1, 337 2 and 3 infections based on virus isolation between 2002 and 2011 in Yamagata

Public health interventions for COVID-19: 340 emerging evidence and implications for an evolving public health crisis

Changes in influenza and other respiratory virus activity 348 during the COVID-19 pandemic-United States

Understanding the potential 351 drivers for respiratory syncytial virus rebound during the COVID-19 pandemic. The 352 Journal of infectious diseases

Review of the causes and 354 implications for the recent increasing parainfluenza virus detection

Prevalence of

Respiratory Viral Infection Using Multiplex Reverse Transcriptase-Polymerase Chain 358

Human parainfluenza virus-associated respiratory tract infection among children and 361 genetic analysis of HPIV-3 strains in Beijing

The hemagglutinin-363 neuraminidase (HN) head domain and the fusion (f) protein stalk domain of the 364 parainfluenza viruses affect the specificity of the HN-F interaction

Molecular characterization and 367 phylogenetic analysis of human parainfluenza virus type 3 isolated from Saudi Arabia

Hemagglutinin-neuraminidase gene sequence-based 370 reclassification of human parainfluenza virus 3 variants

Molecular evolution of the haemagglutinin-neuraminidase gene in 373 human parainfluenza virus type 3 isolates from children with acute respiratory illness

MUSCLE: multiple sequence alignment with high accuracy and 376 high throughput

MEGA X: molecular 378 evolutionary genetics analysis across computing platforms

BEAST 2.5: An advanced 382 software platform for Bayesian evolutionary analysis

ModelFinder: fast model selection for accurate phylogenetic estimates

Posterior 388 summarization in Bayesian phylogenetics using Tracer 1.7

FigTree-Tree Figure Drawing Tool

Unipro UGENE: a unified 395 bioinformatics toolkit

The PyMOL Molecular Graphics System, Version 2.0 Schrödinger

Google Scholar There is no corresponding record for this reference

A mathematical theory of communication

Detecting individual sites subject to episodic diversifying selection

FUBAR: a fast, unconstrained bayesian approximation for 405 inferring selection

Phylogenetic and molecular analyses of 407 human parainfluenza type 3 virus in

Molecular evolution of the hemagglutinin-neuraminidase (HN)

gene in human respirovirus 3. Virus research

The 413 reemergence of seasonal respiratory viruses in Houston, Texas, after relaxing COVID-414 19 restrictions

Epidemiologic features of parainfluenza virus type 1, 2 and 3 infection 417

Seoul and a neighboring area

A molecular 421 epidemiological study of human parainfluenza virus type 3 at a tertiary university 422 20 hospital during 2013-2015 in Catalonia

Human parainfluenza virus infection in severe acute respiratory infection cases in 426

A molecular epidemiological study. Influenza and other 427 respiratory viruses

Off-season RSV epidemics in Australia after easing of 430 COVID-19 restrictions. medRxiv

Influenza lineage 432 extinction during the COVID-19 pandemic?

Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of 436 human parainfluenza virus type III regulates viral growth in vivo

Structure of the haemagglutinin-neuraminidase 439 from human parainfluenza virus type III

441 Functional analysis of amino acids at stalk/head interface of human parainfluenza 442 virus type 3 hemagglutinin-neuraminidase protein in the membrane fusion process

Triggering of human 445 parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) 446 21 protein: an HN mutation diminishes the rate of F activation and fusion

Human parainfluenza virus infection of the airway 450 epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and 451 modulates infectivity

Relative affinity of the human parainfluenza virus type 3 453 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion 454 activity

A Second Receptor Binding 456 Site on Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase 457

Antigenic and 459 structural properties of the hemagglutinin-neuraminidase glycoprotein of human 460 parainfluenza virus type 3: sequence analysis of variants selected with monoclonal 461 antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities

Human parainfluenza virus evolution during 465 lung infection of immunocompromised individuals promotes viral persistence. The 466

Amino acid substitutions in leucine zipper motif in the F-specific domain of human 469 parainfluenza virus 3 HN protein play important roles in the protein function